Fecha de registro: 7 ene 2022


Idiopathic Pulmonary Fibrosis Market was valued at $1,616million in 2016, and is estimated to reach $3,569 million by 2023, growing at a CAGR of 11.9% from 2017 to 2023. Idiopathic pulmonary fibrosis is a type of interstitial lung disease in which the lung tissues are damaged, thereby reducing its oxygen delivering capacity. Increase in incidence of fibrotic diseases poses a high risk factor for idiopathic pulmonary fibrosis. In addition, the rise in geriatric population and the surge in cigarette smoking population boost the market growth. However, the real cause of the disease is unknown due to the unavailability of medications that impedes market growth. Asia-Pacific offers lucrative opportunities for the market growth, owing to the presence of a large pool of patients suffering from fibrotic disease. Idiopathic Pulmonary Fibrosis Treatment Market


Más opciones